Hormone therapy - Revision history

BlankEclair: /* Preventing periods */ Remove erroneous trailing whitespace

2025-04-10T12:48:00Z

Preventing periods: Remove erroneous trailing whitespace

← Older revision		Revision as of 12:48, 10 April 2025
Line 64:		Line 64:

	Methods for permanently stopping menstrual bleeding which are not a form of hormone therapy include [[uterine ablation]], in which the inside of the uterus is cauterized to prevent it from developing or shedding uterine lining, and [[hysterectomy]], the surgical removal of the uterus. Neither of these necessarily prevent other symptoms of menstrual cycles, such as mood swings during premenstruation.		Methods for permanently stopping menstrual bleeding which are not a form of hormone therapy include [[uterine ablation]], in which the inside of the uterus is cauterized to prevent it from developing or shedding uterine lining, and [[hysterectomy]], the surgical removal of the uterus. Neither of these necessarily prevent other symptoms of menstrual cycles, such as mood swings during premenstruation.


	==See also==		==See also==

Ondo at 16:18, 24 December 2024

2024-12-24T16:18:46Z

← Older revision		Revision as of 16:18, 24 December 2024
Line 1:		Line 1:
	{{content warning\|body parts and periods}}		{{content warning\|body parts and periods}}
	{{disclaimer\|~~The Nonbinary Wiki is written by volunteers who are not necessarily experts on~~ medical topics. This wiki and its editors make no representations or warranties of any kind. This wiki and its editors shall not be liable for any physical, psychological, emotional, financial, or commercial damages, prosecutions, or proceedings instituted against any person or entity as a result of the use of information from this file, or any loss, injury, or damage caused thereby. You claim full responsibility for your own health decisions. This wiki will not be held responsible for your actions. Any information here does not constitute legal, financial, medical, business, or other advice. This wiki should not be used to recommend a path for diagnosing or treating any medical condition. For that, you must consult your physician.}}		{{disclaimer\|medical}}

	'''Hormone therapy''' involves blocking the body's sex hormones and/or replacing or supplementing these with a different sex hormone or set of sex hormones. Sex hormones include estrogen (aka oestrogen), progesterone and testosterone. Blockers include antigonadotropins such as leuprorelin.		'''Hormone therapy''' involves blocking the body's sex hormones and/or replacing or supplementing these with a different sex hormone or set of sex hormones. Sex hormones include estrogen (aka oestrogen), progesterone and testosterone. Blockers include antigonadotropins such as leuprorelin.

BinaryBot: Bot: adding archive links to references (error log).

2023-07-17T13:37:44Z

Bot: adding archive links to references (error log).

Show changes

imported>DarkMatterMan4500: Reverted the last edit(s) to revision 28904 by 115.64.0.7

2022-05-13T12:04:52Z

Reverted the last edit(s) to revision 28904 by 115.64.0.7

← Older revision		Revision as of 12:04, 13 May 2022
Line 74:		Line 74:
	<references />		<references />

	[[Category:Transition]]..		[[Category:Transition]]

37.112.150.77: Matt Walsh is a great watch :

2022-05-13T12:01:58Z

Matt Walsh is a great watch :

← Older revision		Revision as of 12:01, 13 May 2022
Line 74:		Line 74:
	<references />		<references />

	[[Category:Transition]].		[[Category:Transition]]..

91.185.57.111: Matt Walsh is a great watch :

2022-05-13T11:50:37Z

Matt Walsh is a great watch :

← Older revision		Revision as of 11:50, 13 May 2022
Line 74:		Line 74:
	<references />		<references />

	[[Category:Transition]]		[[Category:Transition]].

115.64.0.7: Added content

2021-06-15T04:14:16Z

Added content

← Older revision		Revision as of 04:14, 15 June 2021
Line 61:		Line 61:
	* Aromatase inhibitors: aromatase inhibitors increase the testosterone that is already found in any person's body. However, it has menopausal-like side effects (such as fatigue, headache, etc.).		* Aromatase inhibitors: aromatase inhibitors increase the testosterone that is already found in any person's body. However, it has menopausal-like side effects (such as fatigue, headache, etc.).
	* Selective Estrogen Receptor Modulators: SERMs are not commonly used on transmaculine people for this purpose, as they also cause menopausal-like side effects.		* Selective Estrogen Receptor Modulators: SERMs are not commonly used on transmaculine people for this purpose, as they also cause menopausal-like side effects.
	* GnRH agonists: also known as "puberty blockers" within the transgender community, they are not recommended as a long-term solution, as they cause poor bone health.		* GnRH agonists: also known as "puberty blockers" within the transgender community, they are not recommended as a long-term solution, as they can cause poor bone health. Most people who prescribe puberty blockers will check your bone density and/or bone health ever 1-2 years after starting them.

	Methods for permanently stopping menstrual bleeding which are not a form of hormone therapy include [[uterine ablation]], in which the inside of the uterus is cauterized to prevent it from developing or shedding uterine lining, and [[hysterectomy]], the surgical removal of the uterus. Neither of these necessarily prevent other symptoms of menstrual cycles, such as mood swings during premenstruation.		Methods for permanently stopping menstrual bleeding which are not a form of hormone therapy include [[uterine ablation]], in which the inside of the uterus is cauterized to prevent it from developing or shedding uterine lining, and [[hysterectomy]], the surgical removal of the uterus. Neither of these necessarily prevent other symptoms of menstrual cycles, such as mood swings during premenstruation.

imported>Transcendent femboy: I've never heard of danazol being used as a puberty blocker, and it seems like a very odd choice given how danazol is also an anabolic steroid. I chose leuprorelin as an alternative example because Wikipedia says it's one of the most widely used GnRH agonists, but this is of course pretty arbitrary. If there's some reason something else would be a more representative example, feel free to change it! (But if you choose danazol I wanna hear your reasoning.)

2021-05-16T23:08:10Z

I've never heard of danazol being used as a puberty blocker, and it seems like a very odd choice given how danazol is also an anabolic steroid. I chose leuprorelin as an alternative example because Wikipedia says it's one of the most widely used GnRH agonists, but this is of course pretty arbitrary. If there's some reason something else would be a more representative example, feel free to change it! (But if you choose danazol I wanna hear your reasoning.)

← Older revision		Revision as of 23:08, 16 May 2021
Line 2:		Line 2:
	{{disclaimer\|The Nonbinary Wiki is written by volunteers who are not necessarily experts on medical topics. This wiki and its editors make no representations or warranties of any kind. This wiki and its editors shall not be liable for any physical, psychological, emotional, financial, or commercial damages, prosecutions, or proceedings instituted against any person or entity as a result of the use of information from this file, or any loss, injury, or damage caused thereby. You claim full responsibility for your own health decisions. This wiki will not be held responsible for your actions. Any information here does not constitute legal, financial, medical, business, or other advice. This wiki should not be used to recommend a path for diagnosing or treating any medical condition. For that, you must consult your physician.}}		{{disclaimer\|The Nonbinary Wiki is written by volunteers who are not necessarily experts on medical topics. This wiki and its editors make no representations or warranties of any kind. This wiki and its editors shall not be liable for any physical, psychological, emotional, financial, or commercial damages, prosecutions, or proceedings instituted against any person or entity as a result of the use of information from this file, or any loss, injury, or damage caused thereby. You claim full responsibility for your own health decisions. This wiki will not be held responsible for your actions. Any information here does not constitute legal, financial, medical, business, or other advice. This wiki should not be used to recommend a path for diagnosing or treating any medical condition. For that, you must consult your physician.}}

	'''Hormone therapy''' involves blocking the body's sex hormones and/or replacing or supplementing these with a different sex hormone or set of sex hormones. Sex hormones include estrogen (aka oestrogen), progesterone and testosterone. Blockers include antigonadotropins such as ~~danazol~~.		'''Hormone therapy''' involves blocking the body's sex hormones and/or replacing or supplementing these with a different sex hormone or set of sex hormones. Sex hormones include estrogen (aka oestrogen), progesterone and testosterone. Blockers include antigonadotropins such as leuprorelin.

	Many [[nonbinary]], [[genderqueer]] or gender variant people opt not to undergo hormone therapy, or to follow a full hormone therapy regime equivalent to binary transition. However these are not the only options.		Many [[nonbinary]], [[genderqueer]] or gender variant people opt not to undergo hormone therapy, or to follow a full hormone therapy regime equivalent to binary transition. However these are not the only options.

imported>Sekhet: Added some links to the Mad Gender Science Wiki. Changed headings to be more open-ended about the person's assigned gender and gender identity.

2020-08-20T08:28:52Z

Added some links to the Mad Gender Science Wiki. Changed headings to be more open-ended about the person's assigned gender and gender identity.

← Older revision		Revision as of 08:28, 20 August 2020
Line 12:		Line 12:
	Some people opt not to combine hormone therapy with the equivalent binary social transition, or to socially transition in order to access hormone therapy from [[gatekeeper\|medical gatekeepers]], then later 'de-transition' or 're-transition' to their preferred social role or presentation. This may also occur as an unplanned consequence of following whichever aspects of [[transition]] best minimize both social and physical [[gender dysphoria]].		Some people opt not to combine hormone therapy with the equivalent binary social transition, or to socially transition in order to access hormone therapy from [[gatekeeper\|medical gatekeepers]], then later 'de-transition' or 're-transition' to their preferred social role or presentation. This may also occur as an unplanned consequence of following whichever aspects of [[transition]] best minimize both social and physical [[gender dysphoria]].

	== Puberty blockers ==		== Suppression of natural hormones ==

			=== Puberty blockers ===

	''See main article: [[puberty blockers]].''		''See main article: [[puberty blockers]].''

	Puberty blockers are drugs that postpone or temporarily suspend puberty in children and teenagers. They are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal\|last=Stevens\|first=Jaime\|last2=Gomez-Lobo\|first2=Veronica\|last3=Pine-Twaddell\|first3=Elyse\|date=2015-12-01\|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth\|url=http://pediatrics.aappublications.org/content/136/6/1029\|journal=Pediatrics\|language=en\|volume=136\|issue=6\|pages=1029–1031\|doi=10.1542/peds.2015-2849\|issn=0031-4005\|pmid=26527547\|doi-access=free}}</ref><ref>{{cite web \|url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ \|title=Looking at suppressing puberty for transgender kids \|publisher=Associated Press \|date=March 12, 2016}}</ref><ref>{{cite web \|url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ \|title=Transgender Youth Using Puberty Blockers \|publisher=[[KQED]] \|date=August 19, 2016}}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal\|last=Alegría\|first=Christine Aramburu\|date=2016-10-01\|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice\|journal=Journal of the American Association of Nurse Practitioners\|language=en\|volume=28\|issue=10\|pages=521–527\|doi= 10.1002/2327-6924.12363\|pmid=27031444\|issn=2327-6924}}</ref> the studies that have been conducted indicate that these treatments are reasonably safe, and can improve psychological well-being in these individuals.<ref name="lancet_pubertyblockers">{{cite journal \| last=Mahfouda \| first=Simone \| last2=Moore \| first2=Julia K \| last3=Siafarikas \| first3=Aris \| last4=Zepf \| first4=Florian D \| last5=Lin \| first5=Ashleigh \| title=Puberty suppression in transgender children and adolescents \| journal=The Lancet Diabetes & Endocrinology \| publisher=Elsevier BV \| volume=5 \| issue=10 \| year=2017 \| issn=2213-8587 \| doi=10.1016/s2213-8587(17)30099-2 \| pmid=28546095 \| pages=816–826 \| ref=harv\|quote=The few studies that have examined the psychological effects of suppressing puberty, as the first stage before possible future commencement of CSH therapy, have shown benefits."}}</ref><ref>{{cite journal \|last1=Rafferty \|first1=Jason \|title=Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents \|journal=Pediatrics \|date=October 2018 \|volume=142 \|issue=4 \|pages=e20182162 \|url=https://pediatrics.aappublications.org/content/142/4/e20182162 \|accessdate=23 July 2019\|quote=Often, pubertal suppression...reduces the need for later surgery because physical changes that are otherwise irreversible (protrusion of the Adam’s apple, male pattern baldness, voice change, breast growth, etc) are prevented. The available data reveal that pubertal suppression in children who identify as TGD generally leads to improved psychological functioning in adolescence and young adulthood.\|doi=10.1542/peds.2018-2162 \|pmid=30224363 \|doi-access=free }}</ref><ref name="Hembree_et_al">{{cite journal \|last1=Hembree \|first1=Wylie C \|last2=Cohen-Kettenis \|first2=Peggy T \|last3=Gooren \|first3=Louis \|last4=Hannema \|first4=Sabine E \|last5=Meyer \|first5=Walter J \|last6=Murad \|first6=M Hassan \|last7=Rosenthal \|first7=Stephen M \|last8=Safer \|first8=Joshua D \|last9=Tangpricha \|first9=Vin \|last10=T'Sjoen \|first10=Guy G \|title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline \|journal=The Journal of Clinical Endocrinology & Metabolism \|date=November 2017 \|volume=102 \|issue=11 \|page=3881\|quote=Treating GD/gender-incongruent adolescents entering puberty with GnRH analogs has been shown to improve psychological functioning in several domains\|doi=10.1210/jc.2017-01658 \|pmid=28945902 \|doi-access=free }}</ref> In 2019, a study in the journal ''Pediatrics'' found that access to pubertal suppression during adolescence was associated with a lower odds of lifetime suicidality among transgender people.<ref>{{cite journal \|last1=Turban \|first1=Jack \|title=Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation \|journal=Pediatrics \|date=February 2020 \|volume=145 \|issue=2 \|page=e2019172 \|doi=10.1542/peds.2019-1725 \|pmid=31974216 \|url=https://pediatrics.aappublications.org/content/145/2/e20191725 \|accessdate=11 February 2020\|pmc=7073269 }}</ref>		Puberty blockers are drugs that postpone or temporarily suspend puberty in children and teenagers. They are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal\|last=Stevens\|first=Jaime\|last2=Gomez-Lobo\|first2=Veronica\|last3=Pine-Twaddell\|first3=Elyse\|date=2015-12-01\|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth\|url=http://pediatrics.aappublications.org/content/136/6/1029\|journal=Pediatrics\|language=en\|volume=136\|issue=6\|pages=1029–1031\|doi=10.1542/peds.2015-2849\|issn=0031-4005\|pmid=26527547\|doi-access=free}}</ref><ref>{{cite web \|url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ \|title=Looking at suppressing puberty for transgender kids \|publisher=Associated Press \|date=March 12, 2016}}</ref><ref>{{cite web \|url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ \|title=Transgender Youth Using Puberty Blockers \|publisher=[[KQED]] \|date=August 19, 2016}}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal\|last=Alegría\|first=Christine Aramburu\|date=2016-10-01\|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice\|journal=Journal of the American Association of Nurse Practitioners\|language=en\|volume=28\|issue=10\|pages=521–527\|doi= 10.1002/2327-6924.12363\|pmid=27031444\|issn=2327-6924}}</ref> the studies that have been conducted indicate that these treatments are reasonably safe, and can improve psychological well-being in these individuals.<ref name="lancet_pubertyblockers">{{cite journal \| last=Mahfouda \| first=Simone \| last2=Moore \| first2=Julia K \| last3=Siafarikas \| first3=Aris \| last4=Zepf \| first4=Florian D \| last5=Lin \| first5=Ashleigh \| title=Puberty suppression in transgender children and adolescents \| journal=The Lancet Diabetes & Endocrinology \| publisher=Elsevier BV \| volume=5 \| issue=10 \| year=2017 \| issn=2213-8587 \| doi=10.1016/s2213-8587(17)30099-2 \| pmid=28546095 \| pages=816–826 \| ref=harv\|quote=The few studies that have examined the psychological effects of suppressing puberty, as the first stage before possible future commencement of CSH therapy, have shown benefits."}}</ref><ref>{{cite journal \|last1=Rafferty \|first1=Jason \|title=Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents \|journal=Pediatrics \|date=October 2018 \|volume=142 \|issue=4 \|pages=e20182162 \|url=https://pediatrics.aappublications.org/content/142/4/e20182162 \|accessdate=23 July 2019\|quote=Often, pubertal suppression...reduces the need for later surgery because physical changes that are otherwise irreversible (protrusion of the Adam’s apple, male pattern baldness, voice change, breast growth, etc) are prevented. The available data reveal that pubertal suppression in children who identify as TGD generally leads to improved psychological functioning in adolescence and young adulthood.\|doi=10.1542/peds.2018-2162 \|pmid=30224363 \|doi-access=free }}</ref><ref name="Hembree_et_al">{{cite journal \|last1=Hembree \|first1=Wylie C \|last2=Cohen-Kettenis \|first2=Peggy T \|last3=Gooren \|first3=Louis \|last4=Hannema \|first4=Sabine E \|last5=Meyer \|first5=Walter J \|last6=Murad \|first6=M Hassan \|last7=Rosenthal \|first7=Stephen M \|last8=Safer \|first8=Joshua D \|last9=Tangpricha \|first9=Vin \|last10=T'Sjoen \|first10=Guy G \|title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline \|journal=The Journal of Clinical Endocrinology & Metabolism \|date=November 2017 \|volume=102 \|issue=11 \|page=3881\|quote=Treating GD/gender-incongruent adolescents entering puberty with GnRH analogs has been shown to improve psychological functioning in several domains\|doi=10.1210/jc.2017-01658 \|pmid=28945902 \|doi-access=free }}</ref> In 2019, a study in the journal ''Pediatrics'' found that access to pubertal suppression during adolescence was associated with a lower odds of lifetime suicidality among transgender people.<ref>{{cite journal \|last1=Turban \|first1=Jack \|title=Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation \|journal=Pediatrics \|date=February 2020 \|volume=145 \|issue=2 \|page=e2019172 \|doi=10.1542/peds.2019-1725 \|pmid=31974216 \|url=https://pediatrics.aappublications.org/content/145/2/e20191725 \|accessdate=11 February 2020\|pmc=7073269 }}</ref>

	~~== Transfeminine hormone therapy ==~~
	Regular male-to-female hormone replacement therapy (HRT) has the goal of reducing testosterone and increasing estrogens until the level of an average AFAB body is reached. This is done through the administration of estrogens, which also reduce testosterone, allowing for physical feminisation, and sometimes with antiandrogens or progestrogens, which decrease testosterone in case the estrogen therapy wasn't enough on its own. Medications like estradiol in their full doses cause full feminisation (including breast development), and some nonbinary people might not mind these changes. This article, however, will deal with transfeminine transition where a fully feminine development is not desired.

	=== Testosterone deprivation ===		=== Testosterone deprivation ===
Line 33:		Line 32:
	* Selective estrogen receptor modulators (SERMs) will reduce bone density loss and osteoporosis risk. However SERMs will also increase testosterone production in AMAB bodies with low T production (not taking into account HRT).<ref>{{Cite journal\|last=Trost\|first=Landon W.\|last2=Khera\|first2=Mohit\|date=July 2014\|title=Alternative Treatment Modalities for the Hypogonadal Patient\|url=http://link.springer.com/10.1007/s11934-014-0417-2\|journal=Current Urology Reports\|language=en\|volume=15\|issue=7\|pages=417\|doi=10.1007/s11934-014-0417-2\|issn=1527-2737}}</ref>		* Selective estrogen receptor modulators (SERMs) will reduce bone density loss and osteoporosis risk. However SERMs will also increase testosterone production in AMAB bodies with low T production (not taking into account HRT).<ref>{{Cite journal\|last=Trost\|first=Landon W.\|last2=Khera\|first2=Mohit\|date=July 2014\|title=Alternative Treatment Modalities for the Hypogonadal Patient\|url=http://link.springer.com/10.1007/s11934-014-0417-2\|journal=Current Urology Reports\|language=en\|volume=15\|issue=7\|pages=417\|doi=10.1007/s11934-014-0417-2\|issn=1527-2737}}</ref>
	* A low-dose estrogen supplement is much safer than SERMs, but the dose required to avoid bone density loss is enough to cause full feminisation.<ref>{{Cite journal\|last=Hadji\|first=P.\|last2=Colli\|first2=E.\|last3=Regidor\|first3=P.-A.\|date=December 2019\|title=Bone health in estrogen-free contraception\|url=http://link.springer.com/10.1007/s00198-019-05103-6\|journal=Osteoporosis International\|language=en\|volume=30\|issue=12\|pages=2391–2400\|doi=10.1007/s00198-019-05103-6\|issn=0937-941X}}</ref>		* A low-dose estrogen supplement is much safer than SERMs, but the dose required to avoid bone density loss is enough to cause full feminisation.<ref>{{Cite journal\|last=Hadji\|first=P.\|last2=Colli\|first2=E.\|last3=Regidor\|first3=P.-A.\|date=December 2019\|title=Bone health in estrogen-free contraception\|url=http://link.springer.com/10.1007/s00198-019-05103-6\|journal=Osteoporosis International\|language=en\|volume=30\|issue=12\|pages=2391–2400\|doi=10.1007/s00198-019-05103-6\|issn=0937-941X}}</ref>

			=== Suppressing masculinizing and feminizing hormones in adults ===

			Possible options for folks who want to suppress both masculinizing and femininizing hormones at the same time are described in the [https://madgenderscience.miraheze.org/wiki/Experimental_non-binary_HRT#Sex-hormone_antagonists_alone Mad Gender Science Wiki].

			== Feminizing hormone therapy ==
			Regular male-to-female hormone replacement therapy (HRT) has the goal of reducing testosterone and increasing estrogens until the level of an average AFAB body is reached. This is done through the administration of estrogens, which also reduce testosterone, allowing for physical feminisation, and sometimes with antiandrogens or progestrogens, which decrease testosterone in case the estrogen therapy wasn't enough on its own. Medications like estradiol in their full doses cause full feminisation (including breast development), and some nonbinary people might not mind these changes. This article, however, will deal with transfeminine transition where a fully feminine development is not desired.

	=== Prevention of breast development ===		=== Prevention of breast development ===
	There are some specific ways to avoid breast development while allowing for the rest of the feminisation process to happen:		There are some specific ways to avoid breast development while allowing for the rest of the feminisation process to happen. Possible options for feminizing hormone therapy without breast growth are described in detail in the [https://madgenderscience.miraheze.org/wiki/Experimental_non-binary_HRT#Selective_Estrogen_Receptor_Modulators_.28MTX.29 Mad Gender Science Wiki].

	* SERMs (mentioned in the section above) will completely block breast development.		* SERMs (mentioned in the section above) will completely block breast development.
Line 44:		Line 50:
	It's worth noting that most AMAB people will not experience a marked breast development regardless of medication. Likewise, breast development will stop and might even withdraw if the treatment is stopped.<ref>{{Cite book\|url=https://linkinghub.elsevier.com/retrieve/pii/B9780323359559000076\|title=The Breast\|last=Mancino\|first=Anne T.\|last2=Young\|first2=Zachary T.\|last3=Bland\|first3=Kirby I.\|date=2018\|publisher=Elsevier\|isbn=978-0-323-35955-9\|pages=104–115.e5\|language=en\|doi=10.1016/b978-0-323-35955-9.00007-6}}</ref>		It's worth noting that most AMAB people will not experience a marked breast development regardless of medication. Likewise, breast development will stop and might even withdraw if the treatment is stopped.<ref>{{Cite book\|url=https://linkinghub.elsevier.com/retrieve/pii/B9780323359559000076\|title=The Breast\|last=Mancino\|first=Anne T.\|last2=Young\|first2=Zachary T.\|last3=Bland\|first3=Kirby I.\|date=2018\|publisher=Elsevier\|isbn=978-0-323-35955-9\|pages=104–115.e5\|language=en\|doi=10.1016/b978-0-323-35955-9.00007-6}}</ref>

	== ~~Transmasculine~~ hormone therapy ==		== Masculinizing hormone therapy ==
	{{incomplete\|section=yes}}		{{incomplete\|section=yes}}

			Possible options for masculinizing hormone therapy without some potentially undesirable effects, such as acne, are described in the [https://madgenderscience.miraheze.org/wiki/Experimental_non-binary_HRT#Selective_Androgen_Receptor_Modulators_.28FTX.29 Mad Gender Science Wiki].

	=== Preventing periods ===		=== Preventing periods ===
Line 56:		Line 64:

	Methods for permanently stopping menstrual bleeding which are not a form of hormone therapy include [[uterine ablation]], in which the inside of the uterus is cauterized to prevent it from developing or shedding uterine lining, and [[hysterectomy]], the surgical removal of the uterus. Neither of these necessarily prevent other symptoms of menstrual cycles, such as mood swings during premenstruation.		Methods for permanently stopping menstrual bleeding which are not a form of hormone therapy include [[uterine ablation]], in which the inside of the uterus is cauterized to prevent it from developing or shedding uterine lining, and [[hysterectomy]], the surgical removal of the uterus. Neither of these necessarily prevent other symptoms of menstrual cycles, such as mood swings during premenstruation.


	==See also==		==See also==
	*[[Transition]]		*[[Transition]]
			*[[Surgery]]
	*[[Nonbinary healthcare (UK)]]		*[[Nonbinary healthcare (UK)]]

2001:56A:F3CD:AE00:357B:6AFB:81D7:D901: /* Preventing periods */ fixed spelling of 'does' to 'dose'

2020-07-12T23:04:38Z

Preventing periods: fixed spelling of 'does' to 'dose'

← Older revision		Revision as of 23:04, 12 July 2020
Line 49:		Line 49:
	=== Preventing periods ===		=== Preventing periods ===
	Periods are often a source of [[Gender dysphoria\|dysphoria]] for [[AFAB]] nonbinary people. There are several ways of preventing them:<ref>{{Cite journal\|last=Carswell\|first=Jeremi M.\|last2=Roberts\|first2=Stephanie A.\|date=December 2017\|title=Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents\|url=http://www.liebertpub.com/doi/10.1089/trgh.2017.0021\|journal=Transgender Health\|language=en\|volume=2\|issue=1\|pages=195–201\|doi=10.1089/trgh.2017.0021\|issn=2380-193X\|pmc=PMC5684657\|pmid=29142910}}</ref>		Periods are often a source of [[Gender dysphoria\|dysphoria]] for [[AFAB]] nonbinary people. There are several ways of preventing them:<ref>{{Cite journal\|last=Carswell\|first=Jeremi M.\|last2=Roberts\|first2=Stephanie A.\|date=December 2017\|title=Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents\|url=http://www.liebertpub.com/doi/10.1089/trgh.2017.0021\|journal=Transgender Health\|language=en\|volume=2\|issue=1\|pages=195–201\|doi=10.1089/trgh.2017.0021\|issn=2380-193X\|pmc=PMC5684657\|pmid=29142910}}</ref>
	* Testosterone: testosterone will prevent periods (although the changes won't be immediate). The recommended ~~does~~ will change depending on the person.		* Testosterone: testosterone will prevent periods (although the changes won't be immediate). The recommended dose will change depending on the person.
	* Progestogens: these will also prevent (or, at least, decrease) periods, although they are not as effective as testosterone. However, they won't cause masculinisation.		* Progestogens: these will also prevent (or, at least, decrease) periods, although they are not as effective as testosterone. However, they won't cause masculinisation.
	* Aromatase inhibitors: aromatase inhibitors increase the testosterone that is already found in any person's body. However, it has menopausal-like side effects (such as fatigue, headache, etc.).		* Aromatase inhibitors: aromatase inhibitors increase the testosterone that is already found in any person's body. However, it has menopausal-like side effects (such as fatigue, headache, etc.).